Royal Bank of Canada’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9
Closed 7851
2023
Q4
$0 Hold
9
﹤0.01% 7790
2023
Q3
$0 Sell
9
-9
-50% -$92 ﹤0.01% 7826
2023
Q2
$0 Buy
+18
New +$230 ﹤0.01% 7840
2023
Q1
Hold
0
7661
2022
Q4
Sell
-6
Closed -$173 7940
2022
Q3
$0 Buy
6
+3
+100% +$172 ﹤0.01% 8046
2022
Q2
$0 Sell
3
-25
-89% -$2.19K ﹤0.01% 7882
2022
Q1
$2K Sell
28
-38
-58% -$2.28K ﹤0.01% 7524
2021
Q4
$4K Buy
66
+34
+106% +$3.66K ﹤0.01% 7299
2021
Q3
$5K Buy
32
+16
+100% +$4.85K ﹤0.01% 7157
2021
Q2
$10K Buy
+16
New +$10.4K ﹤0.01% 6882
2018
Q2
Hold
0
6853
2018
Q1
Hold
0
6918
2017
Q4
Hold
0
7000
2017
Q3
Hold
0
7067

Royal Bank of Canada's MDVL Position: Q1 2024 in Review

Royal Bank of Canada sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 9 shares.

Royal Bank of Canada first reported a position in MDVL in Q2 2021 and held it in 9 quarters. The position peaked at $10K in Q2 2021. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

  • Royal Bank of Canada reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 9 MedAvail Holdings, Inc. Common Stock shares in Q1 2024.
  • Royal Bank of Canada first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • Royal Bank of Canada's MedAvail Holdings, Inc. Common Stock position peaked at $10K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.